QL1005

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameQL1005
Drug Alias NameQL1005QL-1005
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGDNF family receptor alpha-like agonists
TargetsGlucagon-like peptide 1 receptorGDNF family receptor alpha-like
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing QL Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing QL Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A